Results 161 to 170 of about 30,866 (234)

Progressive Supranuclear Palsy With Post-traumatic Frontal Lobe Damage Mimicking Anti-IgLON5 Antibody Disease. [PDF]

Cureus
Ates Gulkok D, Raj A, Mishan Y, Bloom J, Zaita B, Fekete R.   +5 more
europepmc   +1 more source

Paraneoplastic progressive Supranuclear palsy: a case report and literature review. [PDF]

Oxf Med Case Reports
Simma K, Sikkal A, Khattab H, Haddouali K, Bellakhdar S, Moutawakil BEL, Rafai MA, Otmani HEL.   +7 more
europepmc   +1 more source

The Cambridge Questionnaire for Apathy and Impulsivity Traits (CamQUAIT): a novel assessment tool for frontotemporal lobar degeneration-related syndromes. [PDF]

PLoS One
Lansdall CJ, Williams RS, Coyle-Gilchrist I, Murley AG, Rouse MA, Bateman A, Rowe JB.   +6 more
europepmc   +1 more source

Correction to: Brain linear measurement index in the differential diagnosis between idiopathic normal pressure hydrocephalus and progressive supranuclear palsy. [PDF]

Neurol Sci
Luca A, Donzuso G, Contrafatto F, Mostile G, Cicero CE, Nicoletti A, Zappia M.   +6 more
europepmc   +1 more source

Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy. [PDF]

Mov Disord
Xie T, Golbe LI.
europepmc   +1 more source

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. [PDF]

, 2011
Al-Sarraj S., Beck J., Borroni B., Clarkson M.J., de Silva R., Fox N.C., Hardy J., Holton J.L., Isaacs AM, King A., Lashley T, Mead S, Ourselin S., Revesz T., Rohrer JD, Rossor M.N., Schott JM, Troakes C., Warren J.D., Warren JE, Warrington E.   +20 more
core  

Suicide attempt by a patient with an early phase of progressive supranuclear palsy: a case report. [PDF]

BMC Neurol
Kawai S, Kobayashi R, Sakamoto K, Nemoto K, Morioka D, Numazawa T, Kawakatsu S, Ohta Y, Suzuki A.   +8 more
europepmc   +1 more source

Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy. [PDF]

J Neurol
Lee S, Kim H, Kim R, Jin B, Kim S, Ha SH, Shin JH, Jeon B, Kim HJ, Lee JY.   +9 more
europepmc   +1 more source

Correction to: Evaluation of disproportionately enlarged subarachnoid-space hydrocephalus in progressive supranuclear palsy. [PDF]

Brain Commun
europepmc   +1 more source

Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial. [PDF]

BMJ Neurol Open
Höglinger G, Vandenberghe W, Woitalla D, Corvol JC, Van Tricht H, Ewen C, Van Den Steen B, Rebollo Mesa I, Germani M, Garric E, Arnould T, Jose J, Strong N, De Bruyn S, Buchanan TJ.   +14 more
europepmc   +1 more source